Health Sector – UHC, National Health Policy, Family Planning, Health Insurance, etc.

[op-ed snap] Chasing the cure

Note4Students

From UPSC perspective, the following things are important :

Prelims level : Alzheimer's

Mains level : New drug and its challenges

Context

For nearly two decades, doctors treating Alzheimer’s patients have been frustrated by the lack of advance in medical research. The most advanced drug that is used to treat the disease was developed in 2003. 

Alzheimer’s

  • It was first identified in 1906 by the German physician, Alois Alzheimer. 
  • Drugs currently in use treat the neurodegenerative disorder symptomatically.
  • They leave doctors almost helpless about elderly patients who may forget familiar facts and even the faces of family members.

Latest news

  • Chinese drug regulator approved medicine that improves cognitive functions in patients with mild to moderate levels of the disease. This is a significant breakthrough.
  • Sugar – The new drug, Oligomannate is a sugar derived from a Chinese seaweed.
  • Gut bacteria – It works by modifying gut bacteria to reduce inflammation in the brain. 
  • Clinical trial – A clinical trial on 818 people “demonstrated solid and consistent cognition improvement among those treated versus a control group”. 
  • Different method – The method adopted by Chinese researchers is a departure from Alzheimer’s drug development. Traditionally, it has focussed on attacking the plaque that forms in the brains of patients; this protein build-up interferes with neural signaling. 

Challenges remain

  • In China, the regulatory agency has asked Green Valley to conduct more research on Oligomannate’s safety. 
  • The complete data on how exactly the cognitive function improved for patients on the drug versus those on placebo — and how meaningful that was in the patients’ lives — is still not known outside select circles in China. 
  • Oligomannate must be tested on diverse groups of people to be affirmed as a panacea for Alzheimer’s globally. 
  • These trials need to include many more than 818 individuals. 
  • If the knowledge on the mode of action of Chinese seaweed spreads among medical researchers worldwide, more potent compounds could be developed to target Alzheimer’s.

Back2Basics

Alzheimer’s disease is a progressive disorder that causes brain cells to waste away and die. Alzheimer’s disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person’s ability to function independently.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments